EUVIMEDEUVIMED entdecken
Crossref

Antidislipidemic potential of molecular hydrogen іn metabolic syndrome

Y. S. KRAVCHUK, M. M. KORDA

Experimental and Clinical Physiology and Biochemistry · 20.03.2026 · 104 (4) · 52

DOI: 10.25040/ecpb2025.04.052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Physiology and Biochemistry, online erschienen am 13.03.2026. Verfasst von Y. S. KRAVCHUK und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metabolic syndrome (MS) is characterized by lipid metabolism disorders, including increased triacylglycerols (TAG), total cholesterol, and low-density lipoproteins (LDL), along with decreased high-density lipoproteins (HDL). Molecular hydrogen (H2 ) may influence lipid metabolism through antioxidant properties and regulation of metabolic pathways.

Objective

To study the effect of molecular hydrogen-enriched water on lipid profile parameters in rats with experimentally induced MS. Materials and Methods. MS was induced in rats by prolonged feeding with a high-calorie diet. A subset of rats received water enriched with molecular hydrogen (0.6 ppm). Serum concentrations of TAG, total cholesterol, LDL, and HDL were measured. The effectiveness of H2 intervention was assessed at 6, 12, and 20 weeks after the start of the experiment.

Results

Metabolic syndrome (MS) induced a progressive increase in triacylglycerol (TAG) levels: by 36 % in the 6-week group, 47 % in the 12-week group, and 64 % in the 20-week group compared to controls. H 2 intervention showed an age-dependent effect: changes were minimal in the 6-week group, TAG levels decreased by 9 % in the 12-week group, and by 28 % in the 20-week group relative to MS. Total cholesterol levels in MS animals increased by 57 % (6 weeks), 115 % (12 weeks), and 117 % (20 weeks). H2 treatment significantly reduced total cholesterol by 23 % only in the 20-week group, while the effect in younger groups was negligible. LDL increased by 62 %, 145 %, and 133 % compared to controls, with H2 reducing LDL by 20 % in the 12-week group and 29 % in the 20-week group. HDL decreased by 13–28 % under MS and were minimally affected by H 2 intervention.

Conclusion

MS in rats leads to significant lipid metabolism disturbances that worsen with age and disease duration. H2 intervention partially normalizes TAG, total cholesterol, and LDL, especially during prolonged MS, while its effect on HDL is minimal. These findings support the potential of molecular hydrogen as a therapeutic agent for correcting an atherogenic lipid profile.

Zitieren

APA

KRAVCHUK, Y. S., & KORDA, M. M. (2026). Antidislipidemic potential of molecular hydrogen іn metabolic syndrome. Experimental and Clinical Physiology and Biochemistry, 104(4), 52. https://doi.org/10.25040/ecpb2025.04.052

Vancouver

KRAVCHUK YS, KORDA MM. Antidislipidemic potential of molecular hydrogen іn metabolic syndrome. Experimental and Clinical Physiology and Biochemistry. 2026;104(4):52. doi:10.25040/ecpb2025.04.052

BibTeX
@article{KRAVCHUK2026,
  author = {KRAVCHUK, Y. S. and KORDA, M. M.},
  title = {Antidislipidemic potential of molecular hydrogen іn metabolic syndrome},
  journal = {Experimental and Clinical Physiology and Biochemistry},
  year = {2026},
  volume = {104},
  number = {4},
  pages = {52},
  doi = {10.25040/ecpb2025.04.052}
}
Kostenlos starten →